Céline Dumont

Céline Dumont

Company: Sangamo Therapeutics

Job title: Senior Director, Pharmacology, Preclinical & Safety


TX200: CAR-Treg Cell Therapy for Renal Transplantation 2:30 pm

TX200 is an autologous HLA-A2 specific CAR-Treg cell therapy in development for the prevention of immune-mediated rejection in HLA-A2-mistmatched renal transplantation Preclinical work is promising and shows specificity and selectivity of CAR-Tregs to their target as well as suppressive activity in GvHD and skin transplantation models The STEADFAST study is a multicenter, open-label, single ascending…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.